Left-handedness, learning disability, autoimmune disease, and seizure history influence age at onset and phenotypical targeting of Alzheimer's disease
暂无分享,去创建一个
D. Geschwind | R. Desikan | K. Rankin | P. Scheltens | M. Gorno-Tempini | L. Grinberg | J. Kramer | W. Seeley | Y. Pijnenburg | J. Yokoyama | G. Rabinovici | N. Graff-Radford | B. Miller | R. Ossenkoppele | D. Perry | S. Spina | J. Kramer | H. Rosen | V. Sturm | H. Rosen | W. M. van der Flier | Z. Miller | M. Erkkinen | W. Shwe | E. Wolters | L. Grinberg | K. Rankin | H. Geschwind | Daniel | L. Rosenberg | N. Graff-Radford | W. Seeley | C. David | PsyD | I. E. Allen | S. Jennifer | Y. Pijnenburg | Perry | R. Rademakers | D. Olguin | P. Butler | M. L. Gorno-Tempini | Yokoyama | I. Allen | B. Miller | Michael G. Erkkinen | W. V. D. Flier | Dustin Olguin | MD Zachary A. Miller | PhD Rik Ossenkoppele | Neill | M. F. L. R. Graff-Radford | PhD Isabel E. Allen | BA Wendy Shwe | MD Lynne Rosenberg | Dustin | BS J Olguin | MD Michael G. Erkkinen | MD PhD P. Monroe Butler | MD PhD Salvatore Spina | PhD Jennifer S Yokoyama | MD PhD Philip Scheltens | MD PhD Yolande Pijnenburg | MD PhD Emma Wolters | Ph.D Rosa Rademakers | MD PhD Daniel H. Geschwind | PsyD Joel H. Kramer | MD Howard J. Rosen | MD PhD Lea T. Grinberg | MD William W. Seeley | PhD Virginia Sturm | MD David C Perry | MD Bruce L. Miller | MD Gil D. Rabinovici | MD PhD Maria Luisa Gorno-Tempini | PhD Jennifer S. Yokoyama
[1] Mark Rubin,et al. When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing , 2021, Synthese.
[2] Young Ho Park,et al. Dysregulated Fc gamma receptor–mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis , 2019, Neurobiology of Aging.
[3] J. Marchini,et al. Handedness, language areas and neuropsychiatric diseases: insights from brain imaging and genetics , 2019, Brain : a journal of neurology.
[4] D. Knopman,et al. Systemic inflammation during midlife and cognitive change over 20 years , 2019, Neurology.
[5] W. Ray,et al. The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease , 2019, Front. Aging Neurosci..
[6] Mercedes F. Paredes,et al. Cortical developmental abnormalities in logopenic variant primary progressive aphasia with dyslexia , 2019, Brain communications.
[7] Charles Mock,et al. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set , 2018, Alzheimer disease and associated disorders.
[8] M. Gorno-Tempini,et al. Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy , 2018, JAMA neurology.
[9] P. Scheltens,et al. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer’s disease , 2018, Journal of Neuroinflammation.
[10] L. Piccio,et al. The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity , 2018, Immunity.
[11] J. Grutzendler,et al. Microglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging , 2018, Biological Psychiatry.
[12] B. Wollscheid,et al. Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex , 2018, Journal of Neuroinflammation.
[13] J. Rinne,et al. Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later , 2017, JAMA neurology.
[14] Nick C. Fox,et al. Consensus classification of posterior cortical atrophy , 2017, Alzheimer's & Dementia.
[15] C. Kawas,et al. Dementia in the oldest old: Beyond Alzheimer disease , 2017, PLoS medicine.
[16] M. Goldacre,et al. Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK , 2017, Journal of Epidemiology & Community Health.
[17] Nick C. Fox,et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease , 2016, Alzheimer's & Dementia.
[18] S. Gautam,et al. Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis , 2016, CNS Drugs.
[19] W. Guan,et al. FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis , 2016, Human Genetics.
[20] C. Kawas,et al. Multiple pathologies are common and related to dementia in the oldest-old , 2015, Neurology.
[21] K. Langa,et al. Is the risk of Alzheimer’s disease and dementia declining? , 2015, Alzheimer's Research & Therapy.
[22] J. Álvarez-Sabín,et al. Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold? , 2015, Journal of Neurology.
[23] S. Hider,et al. Association of Polymyalgia Rheumatica With Socioeconomic Status in Primary Care: A Cross-Sectional Observational Study , 2014, Arthritis care & research.
[24] Xue Hua,et al. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. , 2014, JAMA neurology.
[25] Z. Vadasz,et al. Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases , 2014, Clinical Reviews in Allergy & Immunology.
[26] K. Rankin,et al. Handedness and language learning disability differentially distribute in progressive aphasia variants. , 2013, Brain : a journal of neurology.
[27] Dror G. Feitelson,et al. Comparing Performance Heatmaps , 2013, JSSPP.
[28] D. Geschwind,et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[29] Orrin Devinsky,et al. Epilepsy Associated with Systemic Autoimmune Disorders , 2013, Epilepsy currents.
[30] J. Egido,et al. Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice. , 2012, Brain : a journal of neurology.
[31] S. Vesely,et al. Prevalence of primary immune thrombocytopenia in Oklahoma , 2012, American journal of hematology.
[32] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[33] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[34] Nick C Fox,et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.
[35] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[36] I. Mcmanus,et al. Science in the Making: Right Hand, Left Hand. III: Estimating historical rates of left-handedness , 2010, Laterality.
[37] J. Olsen,et al. Autoimmune disease and risk for Parkinson disease , 2009, Neurology.
[38] L. Boulanger,et al. Immune Proteins in Brain Development and Synaptic Plasticity , 2009, Neuron.
[39] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[40] Andrew Gelman,et al. Why We (Usually) Don't Have to Worry About Multiple Comparisons , 2009, 0907.2478.
[41] M. Snowling,et al. A Brief History of Dyslexia , 2008 .
[42] Atlanta,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.
[43] Ken Kleinman,et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[44] I. Palamaras,et al. Lifetime prevalence distribution of chronic discoid lupus erythematosus , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.
[45] Joylee Wu,et al. The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set , 2007, Alzheimer disease and associated disorders.
[46] C. Kawas,et al. Alzheimer's and dementia in the oldest-old: a century of challenges. , 2006, Current Alzheimer research.
[47] Yaakov Stern,et al. Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.
[48] D. Margolis,et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. , 2005, Archives of dermatology.
[49] C. Kreibich,et al. Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.
[50] T. Takai. Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.
[51] Fernando Gomollón. Celiac sprue. , 2002, The New England journal of medicine.
[52] M. Mehler,et al. Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat , 2000, Trends in Neurosciences.
[53] Josemir W Sander,et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.
[54] G C Roman,et al. Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.
[55] K. Boberg,et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. , 1998, Scandinavian journal of gastroenterology.
[56] S J Gange,et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.
[57] M. Cotch,et al. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. , 1996, Arthritis and rheumatism.
[58] L. Phillips. The Epidemiology of Myasthenia Gravis , 2003, Neurologic clinics.
[59] M. Albert,et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. , 1994, Archives of neurology.
[60] P Jallon,et al. Pathological left-handedness. Left-handedness correlatives in adult epileptics. , 1993, Brain : a journal of neurology.
[61] R. Kuljiš,et al. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. , 1993, Journal of neuroimmunology.
[62] N. Bagchi,et al. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. , 1990, Archives of internal medicine.
[63] N. Geschwind,et al. Cerebral lateralization. Biological mechanisms, associations, and pathology: I. A hypothesis and a program for research. , 1985, Archives of neurology.
[64] N. Geschwind,et al. Cerebral lateralization. Biological mechanisms, associations, and pathology: III. A hypothesis and a program for research. , 1985, Archives of neurology.
[65] B. Seltzer,et al. Left‐handedness in early and late onset dementia , 1984, Neurology.
[66] P. Satz,et al. Pathological left-handedness: an explanatory model. , 1972, Cortex; a journal devoted to the study of the nervous system and behavior.